Conseils d'utilisation des traitements anti-TNF et recommandations nationales de bonne pratique labellisées par la Haute Autorité de santé française

V Goëb, M Ardizzone, L Arnaud, J Avouac, A Baillet… - Revue du …, 2013 - Elsevier
L’utilisation des traitements par anti-TNF se doit d’être guidée pour en permettre une
utilisation plus efficace et plus sécurisée. La Société française de rhumatologie et le Club …

Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group

J Avouac, J Fransen, UA Walker, V Riccieri… - Annals of the …, 2011 - ard.bmj.com
Objective To identify a core set of preliminary items considered as important for the very
early diagnosis of systemic sclerosis (SSc). Methods A list of items provided by European …

[HTML][HTML] COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

J Avouac, E Drumez, E Hachulla, R Seror… - The Lancet …, 2021 - thelancet.com
Background Various observations have suggested that the course of COVID-19 might be
less favourable in patients with inflammatory rheumatic and musculoskeletal diseases …

Mapping and predicting mortality from systemic sclerosis

M Elhai, C Meune, M Boubaya, J Avouac… - Annals of the …, 2017 - ard.bmj.com
Objectives To determine the causes of death and risk factors in systemic sclerosis (SSc).
Methods Between 2000 and 2011, we examined the death certificates of all French patients …

Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies

M Elhai, C Meune, J Avouac, A Kahan… - Rheumatology, 2012 - academic.oup.com
Objective. SSc is known as the most severe connective tissue disorder, and to be associated
with a high mortality risk. Some improvements in therapy for SSc have been achieved in …

Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies

J Avouac, P Airò, C Meune, L Beretta… - The Journal of …, 2010 - jrheum.org
Objective. To measure the prevalence of different types of pulmonary hypertension (PH) and
to identify patients with systemic sclerosis (SSc) at highest risk in a multicenter European …

Osteoarthritis of the knee and hip and activity: a systematic international review and synthesis (OASIS)

…, B Avouac, S Rozenberg, P Thoumie, J Avouac… - Joint bone spine, 2006 - Elsevier
The goal of this study was to determine which activities in four domains, daily life, exercises,
sports and occupational activities, should be recommended, in favor or against, for the …

[HTML][HTML] Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global …

…, B Raffeiner, T Thomas, RM Flipo, J Avouac… - Annals of the …, 2021 - ard.bmj.com
Objective To investigate baseline use of biologic or targeted synthetic (b/ts) disease-modifying
antirheumatic drugs (DMARDs) and COVID-19 outcomes in rheumatoid arthritis (RA). …

[HTML][HTML] Genome-Wide Scan Identifies TNIP1, PSORS1C1, and RHOB as Novel Risk Loci for Systemic Sclerosis

Y Allanore, M Saad, P Dieudé, J Avouac… - PLoS …, 2011 - journals.plos.org
Systemic sclerosis (SSc) is an orphan, complex, inflammatory disease affecting the immune
system and connective tissue. SSc stands out as a severely incapacitating and life-…

Cardiac involvement in systemic sclerosis assessed by tissue‐doppler echocardiography during routine care: A controlled study of 100 consecutive patients

C Meune, J Avouac, K Wahbi… - … : Official Journal of …, 2008 - Wiley Online Library
Objective To assess the prevalence of primary cardiac complications in a large population
of patients with systemic sclerosis (SSc), using recently developed echocardiographic …